Press "Enter" to skip to content

New patent expiration for Bausch drug CARDIZEM LA

2
Copyright © DrugPatentWatch. Originally published at New patent expiration for Bausch drug CARDIZEM LA

Annual Drug Patent Expirations for CARDIZEM+LA
Annual Drug Patent Expirations for CARDIZEM+LA

Cardizem La is a drug marketed by Bausch and is included in one NDA. It is available from two suppliers. There is one patent protecting this drug and two Paragraph IV challenges.

CARDIZEM LA drug price trends.

Drug patent litigation for CARDIZEM LA.

This drug has ten patent family members in eleven countries.

The generic ingredient in CARDIZEM LA is diltiazem hydrochloride. Two suppliers are listed for this compound. Additional details are available on the diltiazem hydrochloride profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent expiration for Bausch drug CARDIZEM LA

Comments are closed.

Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry

✓ Insightful Articles & Case Studies

✓ Patent Litigation & Challenges

✓ 505(b)(2) & Biosimilars

✓ Industry Trends

DrugPatentWatch - Make Better Decisions